Open Ledger

Eli Lilly financials in Beancount

Eli Lilly keeps 7 recorded periods through FY2026Q3 as a balanced Beancount ledger — inspect the figures below, then open the live books.

Updated November 8, 2026

Latest figures

Recorded revenue and net income in MUSD (Annual periods).
Period	Period end	Revenue	Net income
`FY2021`	December 31, 2021	$28.3B (28,318.4 MUSD)	$5.6B (5,581.7 MUSD)
`FY2022`	December 31, 2022	$28.5B (28,541.4 MUSD)	$6.2B (6,244.8 MUSD)
`FY2023`	December 31, 2023	$34.1B (34,124.1 MUSD)	$5.2B (5,240.4 MUSD)
`FY2024`	December 31, 2024	$45B (45,042.7 MUSD)	$10.6B (10,590 MUSD)
`FY2025`	December 31, 2025	$65.2B (65,179 MUSD)	$20.6B (20,640 MUSD)

Recorded revenue and net income in MUSD (Quarter periods).

Recorded revenue and net income in MUSD (Quarter periods).
Period	Period end	Revenue	Net income
`FY2026Q2`	June 30, 2026	$23B (22,974 MUSD)	$7.1B (7,095 MUSD)
`FY2026Q3`	September 30, 2026	$24.4B (24,397 MUSD)	$6.5B (6,451 MUSD)

Coverage7